Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M304Revenue $M9.4Net Margin (%)-326.3Altman Z-Score-23.9
Enterprise Value $M348EPS $-0.2Operating Margin %-227.8Piotroski F-Score5
P/E(ttm)--Beneish M-Score-0.9Pre-tax Margin (%)-326.3Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio3.3Cash flow > EarningsY
Price/Sales32.25-y EBITDA Growth Rate %31.1Current Ratio3.5Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-178.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M151ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with NAVB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NAVBJohn Keeley 2015-06-30 Buy $1.24 - $1.67
($1.45)
$ 2.0239%New holding10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NAVB is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


NAVB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-09-01Sell12,500$1.887.45view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-08-03Sell12,500$1.7118.13view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-06-01Sell12,500$1.2462.9view
Troup Gordon ADirector 2015-05-29Buy10,000$1.3154.2view
FORD BRENDAN ADirector 2015-05-21Buy20,000$1.3154.2view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-05-01Sell12,500$1.3351.88view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-04-01Sell20,000$1.5827.85view
GOLDBERG MICHAEL MDirector 2014-11-14Buy100,000$1.0887.04view
FORD BRENDAN ADirector 2014-11-10Buy10,000$1.0396.12view
Nordlicht Mark10% Owner 2014-09-02Sell60,000$1.3648.53view

Quarterly/Annual Reports about NAVB:

    News about NAVB:

    Articles On GuruFocus.com
    Navidea Biopharmaceuticals Reports 4 Insider Trades Mar 18 2013 
    comment on NAVB Mar 15 2013 

    More From Other Websites
    Navidea Awarded $1.8M Fast Track NIH SBIR Grant for Evaluation of a Manocept™ Agent in Kaposi’s... Sep 03 2015
    7:31 am Navidea Biopharma awarded a $1.8 mln fast track NIH SBIR grant for the evaluation of Tc99m... Sep 03 2015
    Navidea Awarded $1.8M Fast Track NIH SBIR Grant for Evaluation of a Manocept™ Agent in Kaposi’s... Sep 03 2015
    Navidea Biopharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference Sep 02 2015
    Navidea Biopharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference Sep 02 2015
    Navidea Biopharmaceuticals Announces Dual Listing on Tel Aviv Stock Exchange Sep 02 2015
    Navidea Biopharmaceuticals Announces Dual Listing on Tel Aviv Stock Exchange Sep 02 2015
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Aug 26 2015
    Navidea Biopharmaceuticals to Present at Sidoti Emerging Growth Conference Aug 25 2015
    Navidea Biopharmaceuticals to Present at Sidoti Emerging Growth Conference Aug 25 2015
    Navidea Biopharmaceuticals to Register Shares for Dual Listing on Tel-Aviv Stock Exchange Aug 24 2015
    Navidea Biopharmaceuticals to Register Shares for Dual Listing on Tel-Aviv Stock Exchange Aug 24 2015
    NAVIDEA BIOPHARMACEUTICALS, INC. Financials Aug 21 2015
    Navidea Reports Publication of Lymphoseek® Comparative Results in Injection Site Pain Study in... Aug 20 2015
    Navidea Reports Publication of Lymphoseek® Comparative Results in Injection Site Pain Study in... Aug 20 2015
    Edited Transcript of NAVB earnings conference call or presentation 30-Jul-15 12:30pm GMT Aug 13 2015
    10-Q for Navidea Biopharmaceuticals, Inc. Aug 12 2015
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Aug 10 2015
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 05 2015
    Navidea reports 2Q loss Jul 30 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK